Clear The Air News Tobacco Blog Rotating Header Image

News and Events Bulletin – 16-30 April 2013

Tobacco News

England’s smoking ban linked to annual five percent drop in emergency admissions for asthma

Emergency admissions for asthma among adults fell by just under five percent in each of the first three years after the ban on smoking in public places was introduced in England, reveals the largest study of its kind, published online in Thorax.

See also:
– Emergency asthma admissions drop following smokefree law, University of Bath
– Short-term impact of the smokefree legislation in England on emergency hospital admissions for asthma among adults: a population-based study, Thorax

Source: Medical Xpress – 15 April 2013

Cancer Research wins second ban on ads attacking plain cigarette packs

A complaint by Cancer Research UK against an ad by JTI that claimed that standardised packaging would result in a “booming” black market has been upheld.

This is  the second time the Advertising Standard Autority has ruled that Gallaher’s claims in adverts about plain packaging were ‘likely to mislead’.

See also:
– Plain packet message for tobacco was ‘misleading’, The Times (£)
– Ad watchdog bashes plain packs claims, City AM
– Tobacco group will continue to ‘express our concerns’, ITV
– Further adverts from Japan Tobacco International ruled misleading, Cancer Research UK

Source: The Guardian – 17 April 2013

Plain packaging lobbyists under fire over links to tobacco company

A campaigning group run by two former senior police officers who lobbied parliament against plain packaging has come under fire after it was revealed that the organisation is linked with the tobacco industry.

Peter Sheridan, a former assistant chief constable in Northern Ireland, and Roy Ramm, previously a commander at Scotland Yard, warned in a letter to the government that standardised packaging would encourage smuggling. However, both men failed to declare that they were part of a group called the Common Sense Alliance that has links with British American Tobacco (BAT).

Deborah Arnott, chief executive of ASH, said: “It beggars belief that Peter Sheridan and Roy Ramm can try to claim they were acting in a personal capacity when one is a director and the other a founder member of an organisation funded by BAT. The government has legal obligations to protect public health policy from commercial interests and it can only do this if the tobacco industry is transparent about its lobbying activities”.

Source: The Observer – 28 April 2013

Dalligate: Leak of OLAF’s Dalli inquiry raises heat on Commission

The unauthorised publication this week of the results of an investigation by OLAF, the European Union’s anti-fraud office, into John Dalli has forced the European Commission to defend its decision to demand his resignation as European commissioner for health and consumer policy.

Malta Today, a newspaper, published on 28 April a leaked report of OLAF’s investigation into Dalli, Malta’s former European commissioner. The leaked version, which is missing two pages and 20 annexes, contains no direct evidence that Dalli was aware of an offer made by a Maltese businessman, Silvio Zammit, to influence – through his links with Dalli – imminent tobacco legislation, in exchange for €70 million.

See also:
Dalligate – the OLAF report, Times of Malta
– Witness reveals she had lunch with OLAF investigator after interrogation, Times of Malta
– Whistleblower MEP claims EU cover-up over Dalligate, Public Service Europe

Source: European Voice – 30 April 2013

Bob Blackman MP: Saying no to the tobacco industry

Bob Blackman, MP for Harrow East, former leader of Brent Council, member of the Communities and Local Government Select Committee and secretary of the All-Party Parliamentary Group on Smoking and Health, sets out the perils for local authorities as the tobacco industry ramps up its lobbying tactics.
Source: LGC – 16 April 2013

Experts propose strategies to reduce, end tobacco use

Several scholars, scientists and policy experts address the question of what it would take to end tobacco use for good in a supplement to the journal Tobacco control.
Source: University of Michigan – 16 April 2013

Match of the Day: QPR’s anti-smoking scheme (video)

Match of the Day visits Premier League club Queens Park Rangers to learn more about a new scheme designed to prevent local youngsters from taking up smoking.

The club’s Health Stars initiative aims to promote better health and wellbeing in the local community.

Source: BBC Sports – 18 April 2013

“Saving Lives and Preventing Misery”, Memoirs of Professor John Crofton, by Dr David Kilpatrick

Professor John Crofton (1912-2009) was one of the outstanding physicians of the 20th century. He led the pioneering medical team that first established that tuberculosis could be cured by combination chemotherapy (“the Edinburgh method”). He was also a prominent public health campaigner who did much to change public and political attitudes towards tobacco smoking and helped in the foundation of ASH.

His memoirs describe his childhood years, his student days and climbing holidays, his war years in the RAMC, his radical approach to the treatment of TB, his roles as Edinburgh University Vice-Principal and President of the Royal College of Physicians of Edinburgh, and finally his extensive public health campaigns waged after his retirement from medical practice.

Source: FastPrint Publishing – 15 April 2013
Parliamentary News

Northern Ireland: Tobacco Retailers Bill: Second Stage

Transcript of the debates of the Executive Committee for the second stage of the Northern Ireland Tobacco Retailers Bill.
Source: They Work For You – 23 April 2013

Committe Meeting: New clause on smoking in cars

Transcript of a Public Bill Committee meeting on a new clause to the Children and Family Bill introducing an offence of failing to prevent smoking in a private vehicle when children are present. The Clause was eventually withdrawn.
Source: Hansard – 25 April 2013

Parliamentary question: E-cigarettes

Mr Laurence Robertson: To ask the Secretary of State for Health what recent assessment he has made of any health risks associated with electronic cigarettes; and if he will make a statement.

Norman Lamb: There are a number of products on the market which claim to contain nicotine, such as electronic cigarettes, which are widely available but are not licensed medicines. Currently, any nicotine-containing product (NCP) which claims or implies that it can treat nicotine addiction is considered to be a medicinal product. This approach has allowed NCPs which do not make such claims to be used and sold without the safeguards built into the regulation of medicinal products.

In March 2011, the Medicines and Healthcare products Regulatory Agency (MHRA) published the outcome of a public consultation on whether to bring all NCPs within the medicines licensing regime. The response to the consultation highlighted the need for further information to inform a decision. Since this time, the MHRA co-ordinated a programme of research to advise on:

an investigation of the levels of nicotine which have a significant physiological effect through its pharmacological action;

the nature, quality and safety of unlicensed NCPs;

the actual use of unlicensed NCPs (excluding tobacco products) in the marketplace;

the efficacy of unlicensed NCPs in smoking cessation; and

modelling of the potential impact of bringing these products into medicines regulation on public health outcomes.

The MHRA is currently bringing to a conclusion this period of scientific and market research with a view to a final decision on the application of medicines regulation later this year.

Column 740W

Source: Hansard – 22 April 2013
Industry Watch

How UK tobacco firms stay one step ahead of the regulator: study

A new study has shed more light on the tobacco industry’s tactics to undermine attempts to reduce smoking.

The study, published in the journal Addiction, reveals how tobacco companies would use premium brands to absorb tax increases, as such brands are usually bought by high-income earners who are less likely to be deterred by increasing prices.

Such a tactic ensures that a price gap can be maintained between budget and premium brands, helping maintain their customer base and, by extension, protect their profits.

Source: The Globe and Mail – 17 April 2013

USA: Reynolds American first-quarter cigarette volume slumps

Despite an estimated 6.2% drop in cigarette volumes, Reynolds American profit jumped 88% in the first quarter of the year.
Source: ADVFN – 23 April 2013

Protest as BAT announces that price hikes offset declining cigarette sales

The second-biggest tobacco firm in the world announced at its AGM that its revenues had risen despite falling volume sales.

British American Tobacco (BAT) said that in the first quarter of the year, price hikes had driven a 1% rise in revenues. This was despite a 3.4% fall in the amount of tobacco it sold.

See also:
– BAT Sales Top Estimates as Higher Prices Offset Lower Volume, Washington Post
– BAT feels pinch as smokers kick the habit, The Times (£)
– Asian sales keeps fire burning under British American Tobacco, The Times (£)

As the meeting was taking place at Banqueting House in Whitehall, a group of about 70 young people from various parts of the country were protesting outside, calling for standardised packaging to be introduced. They later went to the House of Lords to meet MPs to discuss the subject.

Images of the protest and the meeting can be seen on our flickr account here.

Source: City AM – 26 April 2013

Altria to launch e-cig in response to fall in cigarette sales

Altria Group Inc., which reported a reduction in cigarette volumes for the first-quarter, will enter the e-cigarette market later this year, a move to address a change in the market.

Profitability grew 16% for the quarter, aided by higher pricing for cigarettes and smokeless products, as well as a credit tied to a landmark tobacco settlement.

Source: ADVFN – 25 April 2013

Imperial Tobacco to develop e-cigarettes as profits drop

Imperial Tobacco, the world’s fourth-largest cigarette group by market share, said it had set up a venture to develop electronic cigarettes, as it battles an increasingly tough consumer environment in Europe.

See also:
– Imperial sees revenues and profits fall in first half, London South East

Source: Reuters – 30 April 2013

Philip Morris Int’l 1Q profit falls nearly 2%

Cigarette maker Philip Morris International Inc. said that its first-quarter profit fell nearly 2% on a decline in the number of cigarettes sold.
Source: Yahoo!/AP – 18 April 2013

Japan Tobacco expects record full-year profit

Japan Tobacco Inc. said it expects record profits for the current business year ending March 2014, aided by a solid performance of its overseas business and the yen’s weakness.
Source: Wall Street Journal – 25 April 2013
Recent Research

Early dialogue most effective in deterring teen tobacco, alcohol use

Early, substantive dialogue between parents and their children about the ills of tobacco and alcohol use can be more powerful in shaping teen behavior than advertising, marketing or peer pressure, a University of Texas at Arlington marketing researcher has shown.
Source: Medical Xpress – 25 April 2013

Protection from secondhand smoke in countries belonging to the WHO European Region

Objectives Comprehensive smokefree laws, as recommended by the WHO Framework Convention of Tobacco Control (WHO FCTC), are the most effective tool to protect the population from secondhand smoke (SHS) and to ensure healthy environments. Studies evaluating how laws govern SHS protection are scarce. This study assessed the level of protection from SHS of laws from countries belonging to the WHO European Region.

Methods A new methodology system was developed to evaluate the smokefree legislation according to the principles provided by the WHO guidelines for the correct implementation of Article 8 of the FCTC. For each law, six main sectors and 28 facilities were evaluated.

Results Overall 68 laws from 48 countries from the WHO European Region were reviewed. ‘Education’ and ‘Public transport’ were the most protected sectors from SHS. Many WHO European laws do not provide protection from SHS across all public sectors. For example, 48.5% of general health facilities and 71.2% of restaurants are unprotected from SHS. The level of protection provided in the 28 facilities studied was low; many WHO European laws still allow smoking under certain conditions, permitting smoking in designated and/or ventilated areas.

Conclusions Nine years after the adoption of the WHO FCTC there are still legal formulas in which smoking is allowed in several facilities, through the inclusion of separated areas, ventilated areas and other conditions. Tobacco control efforts still face the challenge of eradicating the legal clauses that prevent 100% smokefree environments.

Martínez, C., et al., Protection from secondhand smoke in countries belonging to the WHO European Region: an assessment of legislation, Tob Control doi:10.1136/tobaccocontrol-2012-050715

Source: Tobacco Control – 17 April 2013

Light smokers are less likely to receive advice to quit from their GP

Background: A substantial proportion of smokers nowadays smoke fewer than 10 cigarettes per day (cpd). These ‘light’ smokers are still exposed to significant health risks but may not receive as much attention from health professionals as heavier smokers. The Netherlands and England are two countries with very different smoking cessation treatment climates and may vary in the extent to which GPs advise on smoking cessation.

Objectives: To assess whether Dutch and English light smokers (< 10 cpd) are less likely to receive advice to stop smoking during a consultation with their GP than moderate-to-heavy smokers (≥ 10 cpd).

Methods: We compared data from two series of national surveys: the Dutch ‘Continuous Survey of Smoking Habits’ and the English ‘Smoking Toolkit Study’. We included respondents to both surveys from February 2010 to December 2011, aged 16+ years, who consulted their GP in the previous 12 months.

Results: A total of 7734 smokers responded to the surveys in the Netherlands and 10 383 in England. The percentage of Dutch smokers who received advice to quit from their GP was 22.6% (95% CI = 21.5–23.7) compared with 58.9% (95% CI = 57.6–60.2) of English smokers. Light smokers were less likely to receive advice to quit than moderate-to-heavy smokers, both in the Netherlands (OR = 0.57, 95% CI = 0.50–0.65) and in England (OR = 0.64, 95% CI = 0.57–0.72).

Conclusion: Smokers in the Netherlands are less than half as likely to receive advice to quit from their GP as smokers in England. In both countries, light smokers are less likely to receive advice to quit from their GP than moderate-to-heavy smokers.

Kotz, D., et al., Light smokers are less likely to receive advice to quit from their GP than moderate-to-heavy smokers: A comparison of national survey data from the Netherlands and England, European Journal of General Practice, doi:10.3109/13814788.2013.766792

Source: Informa – 20 March 2013

Expansion of the marketing license for NRT

Background: In December 2009 and January 2010, the UK Medicines and Healthcare Products Regulatory Agency expanded the marketing license for a number of nicotine replacement therapies (NRTs) to include smoking reduction without an intention to stop completely. This study examined whether this was associated with a change in incidence of use of NRT for harm reduction (i.e., smoking reduction and/or temporary abstinence) and in smoking cessation activity.

Methods: Data were taken from 10,497 smokers who took part in the Smoking Toolkit Study, which involves monthly representative household surveys of adults aged 16+ in England. Incidence of use of NRT for smoking reduction and/or temporary abstinence and attempts to stop smoking in 2009 was compared with the 2 years following the expansion of the marketing license.

Results: Expansion of the license was not associated with an increase in incidence of NRT use for harm reduction, which was already substantial prior to the change. The odds of a quit attempt were lower in the second year following the license change relative to the year before, but there was no change in the success of quit attempts.

Conclusions: Expansion of the UK marketing license for NRT to include smoking reduction without the intention of quitting was not associated with an increase in use of NRT for this purpose. It was followed by a reduction in the incidence of quit attempts (but not their success) although this may have been a continuation of a pre-existing decline.

Beard, E., et al., Was the Expansion of the Marketing License for Nicotine Replacement Therapy in the United Kingdom to Include Smoking Reduction Associated With Changes in Use and Incidence of Quit Attempts?, Nicotine Tob Res(2013) doi: 10.1093/ntr/ntt044

Source: Oxford Journals – 10 April 2013

Will the European Union’s new tobacco tax legislation lead to reductions in smoking prevalence?


Introduction: The European Union (EU) requires member states to apply minimum taxes on manufactured cigarettes. One of such taxes has operated in Spain since 2006. This study evaluates the impact of this reform of the tax regime on manufactured cigarette prices and on smoking prevalence, drawing implications for European tobacco tax policy.

Methods: Quasi-experimental design with treatment and control territories. We analyze series for prices before and after the reform and use cross-sectional health surveys to implement differences-in-differences estimators for smoking prevalence.

Results: Under the minimum tax regime, prices increased three times faster in the treatment territory. However, the new regime did not affect smoking prevalence among males, either shortly after its enactment or 3 years hence. For women, we find no significant effects on prevalence in the short run, and point estimates ranging between −3.36% and −4.3% 3 years hence, although only one of these is statistically significant.

Conclusions: The new tax regime affected cigarette prices in the intended direction. However, we find only weak evidence for a reduction in prevalence among women. The availability of cheap, fine-cut tobacco appears as the most likely cause for the poor results in terms of smoking prevalence. EU member states that have introduced a minimum tax on manufactured cigarettes might achieve little in terms of reductions in smoking prevalence if they allow a tax gap between fine-cut tobacco and manufactured cigarettes. In this sense, it is unfortunate that EU legislation consecrates a differential treatment for the two products.

López-Nicolás, A., et al., Will the European Union’s New Tobacco Tax Legislation Lead to Reductions in Smoking Prevalence? Evidence From a Quasi-experiment in Spain, Nicotine Tob Res (2013) doi: 10.1093/ntr/ntt038

Source: Oxford Journals – 04 April 2013

31 May 2013 – World No Tobacco Day 2013

Every year, on 31 May, The World Health Organisation and partners everywhere mark World No Tobacco Day, highlighting the health risks associated with tobacco use and advocating for effective policies to reduce tobacco consumption.

The theme for World No Tobacco Day 2013 is: ban tobacco advertising, promotion and sponsorship.

Venue: Everywhere

20 June 2013 – ASH Scotland 40th Anniversary Conference: Towards a Generation Free From Tobacco

Bringing together delegates from Scotland, the rest of the UK and across the world, the conference will provide an opportunity for tobacco control advocates, policy makers, researchers, health practitioners and community development professionals to learn from international good practice and innovation.

Themes to be explored include industry and regulation, protection from second-hand smoke, youth smoking prevention, cessation services in our communities and the role of advocacy in driving policy.

There will be a special focus on addressing health inequality and new ways of working with hard-to-reach groups.

Venue: The John McIntyre Conference Centre Holyrood Park, University of Edinburgh, Scotland

20 June 2013 – Towards a generation free from tobacco

Join speakers from the UK and from Uruguay, Belgium, Finland, New Zealand and Hong Kong for an engaging and interactive international conference exploring the ideas and actions that will drive us forward – towards a generation free from tobacco.
Venue: John McIntyre Conference Centre, Edinburgh

27 June 2013 – UK National Smoking Cessation Conference

Key topics for 2013 include the NICE guidance on tobacco harm reduction, e-cigarettes, electronic aids to cessation, getting the most out of current treatments, smoking cessation and mental health, international comparisons of tobacco treatment, treating pregnant smokers and the politics of tobacco growing – making it an essential event for everyone in the smoking cessation and tobacco control fields.
Venue: Victoria Park Plaza, London

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>